Crohn’s disease is a chronic inflammatory condition of the gastrointestinal tract (GIT) that can affect any part of the digestive tube, but most commonly involves the terminal ileum and proximal colon. Patients may initially present with nonspecific symptoms, such as abdominal pain, diarrhea and fatigue, but may also present with more debilitating symptoms (1).

Early detection and accurate assessment are crucial for disease management, and imaging modalities such as CTe and MRe play a critical role in the evaluation of intestinal involvement. The imaging spectrum of CD is broad, ranging from superficial lesions to aphthous ulcers with penetrating lesions such as abscesses and fistulas, and strictures. These modalities are also essential for monitoring disease extent, activity and severity, with significant implications in treatment management (2).